Cullinan Oncology ( NASDAQ:CGEM – Get Rating ) and Cellectis ( NASDAQ:CLLS – Get Rating ) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their analyst recommendations, earnings, dividends, institutional ownership, risk, profitability and valuation. Analyst Ratings This is a breakdown of recent ratings and price targets for Cullinan Oncology and Cellectis, as reported by MarketBeat.com. Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Cullinan Oncology 0 0 4 0 3.

https://www.dailypolitical.com/2023/06/18/head-to-head-analysis-cullinan-oncology-nasdaqcgem-versus-cellectis-nasdaqclls.html

#dailypolitical